XNAS · KLRA
-1.66% · -$0.2900 · Vol 436.8K
Market closed · last close 4:00 PM ET · price as of 16:01:18 ET
Kailera Therapeutics, Inc. Common Stock

Kailera Therapeutics, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$17.17
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Analyst data unavailable at compute time
KLRA
Kailera Therapeutics, Inc. Common Stock
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

64/ 100
Veridion Score
BUY BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is KLRA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading KLRA catalysts
About Kailera Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Listed since
2026
Country
US

Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$17.52
Day high
$17.96
Day low
$17.00
Previous close
$17.46
52W high
$26.00
-33.96% from high
52W low
$16.74
5% of range
Market cap
$2.2B
EPS
$-4.3600
Beta
1.28
Shares out
129.6M
Volume
436.8K
0.86× rel vol
Avg volume
509K
VWAP
$17.33
Price history computed in-house
1W
-7.24%
1M
-2.94%
3M
-20.40%
SMA 50 $19.21 · below
SMA 200 Not reported · Not reported
52W position 5%

KLRA overview

Veridion Score
64
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around KLRA.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading KLRA Form 4 filings
Public disclosures

Congress activity in KLRA

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for KLRA in the cached public ledger.

Federal contracts

KLRA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for KLRA in this window.
Lobbying spend

KLRA lobbying filings, year to date.

Registered lobbying filings matched to Kailera Therapeutics, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for KLRA in this window.
Loading news for KLRA
Analyst ratings
Sovereign unlock shows live analyst consensus for KLRA.
Options
Sovereign unlock shows live options positioning for KLRA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.